Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,234,374
+$17,792,093 QoQ
Shares Held
249,259
+377.3% QoQ
Ownership
0.179%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#85
of 473 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Mar 31, 2025CallValue
$803,800
CallShares
20,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names. CYTK ranks #1 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
This page
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in CYTK
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,234,374 | 249,259 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,442,281 | 52,227 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $21,803,369 | 343,144 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $3,450,833 | 85,863 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $803,800 | 20,000 | Call | Sole | 2025-05-14 | |
| 2024-12-31 | $438,600 | 9,324 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,229,555 | 117,984 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,035,109 | 92,933 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $518,814 | 7,400 | Call | Sole | 2024-05-14 | |
| 2024-03-31 | $3,173,459 | 45,264 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $261,657 | 3,134 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,031,434 | 204,733 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,944,537 | 212,892 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $9,517,100 | 270,449 | Shares | Other | 2023-05-11 | |
| 2022-12-31 | $7,392,278 | 161,333 | Shares | Other | 2023-02-13 | |
| 2022-06-30 | $3,879,494 | 98,740 | Shares | Sole | 2022-08-22 | |
| 2021-12-31 | $1,185,672 | 26,013 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,737,147 | 76,585 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $623,681 | 31,515 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $1,244,084 | 53,486 | Shares | Other | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||